MXPA02005008A - Formas de estado solido de 5-((6 -((2-fluorofenil) metoxi)-2 -naftalenil)metil)-2, 4-tiazolidinediona. - Google Patents

Formas de estado solido de 5-((6 -((2-fluorofenil) metoxi)-2 -naftalenil)metil)-2, 4-tiazolidinediona.

Info

Publication number
MXPA02005008A
MXPA02005008A MXPA02005008A MXPA02005008A MXPA02005008A MX PA02005008 A MXPA02005008 A MX PA02005008A MX PA02005008 A MXPA02005008 A MX PA02005008A MX PA02005008 A MXPA02005008 A MX PA02005008A MX PA02005008 A MXPA02005008 A MX PA02005008A
Authority
MX
Mexico
Prior art keywords
thiazolidinedione
naphthalenyl
fluorophenyl
methoxy
methyl
Prior art date
Application number
MXPA02005008A
Other languages
English (en)
Spanish (es)
Inventor
Mark C Andres
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MXPA02005008A publication Critical patent/MXPA02005008A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
MXPA02005008A 1999-11-19 2000-11-17 Formas de estado solido de 5-((6 -((2-fluorofenil) metoxi)-2 -naftalenil)metil)-2, 4-tiazolidinediona. MXPA02005008A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16651599P 1999-11-19 1999-11-19
PCT/US2000/031705 WO2001036401A1 (en) 1999-11-19 2000-11-17 Solid state forms of 5-[[6-[(2-fluorophenyl)methoxy]-2-naphthalenyl]methyl]-2,4-thiazolidinedione

Publications (1)

Publication Number Publication Date
MXPA02005008A true MXPA02005008A (es) 2003-10-14

Family

ID=22603643

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02005008A MXPA02005008A (es) 1999-11-19 2000-11-17 Formas de estado solido de 5-((6 -((2-fluorofenil) metoxi)-2 -naftalenil)metil)-2, 4-tiazolidinediona.

Country Status (16)

Country Link
EP (1) EP1235817A1 (bg)
JP (1) JP2003514807A (bg)
CN (1) CN1423639A (bg)
AR (1) AR029409A1 (bg)
AU (1) AU1776701A (bg)
BG (1) BG106692A (bg)
BR (1) BR0015702A (bg)
CA (1) CA2391429A1 (bg)
HU (1) HUP0203280A3 (bg)
IL (1) IL149593A0 (bg)
MX (1) MXPA02005008A (bg)
NO (1) NO20022329L (bg)
RU (1) RU2002113123A (bg)
WO (1) WO2001036401A1 (bg)
YU (1) YU35602A (bg)
ZA (1) ZA200204873B (bg)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104055774A (zh) * 2013-03-22 2014-09-24 天津药物研究院 一种稳定的非晶态盐酸吡格列酮复合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594016A (en) * 1992-12-28 1997-01-14 Mitsubishi Chemical Corporation Naphthalene derivatives
JP2845743B2 (ja) * 1992-12-28 1999-01-13 三菱化学株式会社 新規なナフタレン誘導体
JP4023697B2 (ja) * 1996-11-14 2007-12-19 三菱化学株式会社 ナフタレン誘導体の製造方法
PL348502A1 (en) * 1998-11-20 2002-05-20 Mitsubishi Chem Corp Chrystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione

Also Published As

Publication number Publication date
CA2391429A1 (en) 2001-05-25
BR0015702A (pt) 2002-07-16
HUP0203280A3 (en) 2003-07-28
IL149593A0 (en) 2002-11-10
EP1235817A1 (en) 2002-09-04
HUP0203280A2 (hu) 2003-01-28
CN1423639A (zh) 2003-06-11
AR029409A1 (es) 2003-06-25
WO2001036401A1 (en) 2001-05-25
NO20022329L (no) 2002-07-09
RU2002113123A (ru) 2004-01-20
YU35602A (sh) 2006-05-25
ZA200204873B (en) 2003-11-26
JP2003514807A (ja) 2003-04-22
NO20022329D0 (no) 2002-05-15
AU1776701A (en) 2001-05-30
BG106692A (bg) 2003-03-31

Similar Documents

Publication Publication Date Title
ZA200000894B (en) 4-Phenyl-pyridine derivatives.
ZA200201055B (en) Amino-triazolopyridine derivatives.
ZA200203316B (en) New use and novel n-azabicyclo-amide derivatives.
AU6314900A (en) Biarylurea derivatives
AU6714700A (en) Cyclopropylindole derivatives
AU3958100A (en) New compounds, their preparation and use
AU3957900A (en) New compounds, their preparation and use
ZA200109595B (en) 13-methyl-erythromycin derivatives.
HK1046411A1 (en) 5-Phenyl-pyrimidine derivatives.
ZA200006352B (en) Compound napkin.
ZA9811925B (en) Thiazole derivatives.
AU3819200A (en) 2,4-diamino-pyrimidine derivatives
AU5429000A (en) Novel bicyclonucleoside derivatives
AU2231397A (en) Thiazolidine-2,4-dione derivatives
ZA200108718B (en) Thiazolidinedione derivative and its use as antidiabetic.
HK1045151A1 (en) Thiazolidinedione derivative and its use as antidiabetic.
ZA200201276B (en) 3-Amino-2-phenyl-propane derivatives.
AU2002218400A1 (en) 3-substituted 2,7-naphthyridin-1-yl derivatives
HK1045304A1 (en) Thiazolidinedione derivative and its use as antidiabetic.
MXPA02005008A (es) Formas de estado solido de 5-((6 -((2-fluorofenil) metoxi)-2 -naftalenil)metil)-2, 4-tiazolidinediona.
MXPA01011285A (es) Derivados de tio-oxindol.
AU7961800A (en) Thiazolidinedione derivatives
AU5914200A (en) Amino-alkyl derivatives
AU6262300A (en) Indolinylamide derivatives
AU1558300A (en) 1-cycloalkylpyrazoyl-benzoyl derivatives